Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
NCT ID: NCT06890598
Last Updated: 2026-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
700 participants
INTERVENTIONAL
2025-03-27
2032-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
NCT05508906
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)
NCT04123366
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
NCT04956640
A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC
NCT00743938
A Study of LY2875358 in Participants With Advanced Cancer
NCT01287546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Part A: Olomorasib + Pembrolizumab
Participants will receive olomorasib administered orally in combination with pembrolizumab intravenously (IV) for up to 1 year followed by olomorasib alone for up to 3 years of total treatment.
Olomorasib
Administered orally.
Pembrolizumab
Administered intravenously (IV).
Part A: Placebo + Pembrolizumab
Participants will receive placebo administered orally in combination with pembrolizumab administered IV for up to 1 year followed by placebo alone for up to 3 years of total treatment.
Pembrolizumab
Administered intravenously (IV).
Placebo
Administered orally.
Part B: Olomorasib + Durvalumab
Participants will receive olomorasib administered orally in combination with durvalumab administered IV for up to 1 year followed by olomorasib alone for up to 3 years of total treatment.
Olomorasib
Administered orally.
Durvalumab
Administered IV.
Part B: Placebo + Durvalumab
Participants will receive placebo administered orally in combination with durvalumab administered IV for up to 1 year followed by placebo alone for up to 3 years of total treatment.
Durvalumab
Administered IV.
Placebo
Administered orally.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Olomorasib
Administered orally.
Pembrolizumab
Administered intravenously (IV).
Durvalumab
Administered IV.
Placebo
Administered orally.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Part A
1. Clinical Stage II-IIIB (N2) treated with presurgical chemoimmunotherapy, with residual tumor present at time of surgery. Patients with a pathologic complete response are not eligible.
2. Pathologic Stage II-IIIB (N2) NSCLC treated with initial upfront resection.
* Part B - Clinical Stage III, unresectable NSCLC, without progression on concurrent platinum-based chemoradiotherapy.
* Must have disease with evidence of KRAS G12C mutation.
* Must have known programmed death-ligand 1 (PD-L1) expression
* Must have an ECOG performance status of 0 or 1.
* Able to swallow oral medication.
* Must have adequate laboratory parameters.
* Contraceptive use should be consistent with local regulations for those participating in clinical studies.
* Women of childbearing potential must
* Have a negative pregnancy test.
* Not be breastfeeding during treatment
Exclusion Criteria
* Have another type of cancer that is progressing or required active treatment within the past 3 years before screening.
* Have an active autoimmune disease that required systemic treatment in the past 2 years. Endocrine replacement therapy is allowed.
* Had any immune-related side effect or allergic reaction (Grade 3 or higher) from a previous immunotherapy medicine, or any immune-related side effect greater than Grade 1 that has not resolved. This does not apply for people with hormone-related diseases who are now on stable hormone replacement therapy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Eli Lilly and Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Role: STUDY_DIRECTOR
Eli Lilly and Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clearview Cancer Institute
Huntsville, Alabama, United States
Infirmary Cancer Care
Mobile, Alabama, United States
The University of Arizona Cancer Center - North Campus
Tucson, Arizona, United States
Highlands Oncology Group
Springdale, Arkansas, United States
UCLA Hematology/Oncology - Santa Monica
Los Angeles, California, United States
Profound Research LLC
Oceanside, California, United States
University of California, Irvine (UCI) Health - UC Irvine Medical Center
Orange, California, United States
Stanford Cancer Center
Palo Alto, California, United States
Kaiser Permanente San Diego Mission Road
San Diego, California, United States
BASS Cancer Center
Walnut Creek, California, United States
Hartford Hospital (HH)
Hartford, Connecticut, United States
Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
Boca Raton Regional Hospital
Boca Raton, Florida, United States
Florida Cancer Specialists - South
Fort Myers, Florida, United States
University of Florida - Jacksonville
Jacksonville, Florida, United States
Miami Cancer Institute at Baptist Health, Inc.
Miami, Florida, United States
Florida Cancer Specialists North
St. Petersburg, Florida, United States
Comprehensive Hematology Oncology
St. Petersburg, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
Florida Cancer Specialists East
West Palm Beach, Florida, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
University of Illinois at Chicago
Chicago, Illinois, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Captain James A. Lovell Federal Health Care Center
North Chicago, Illinois, United States
Springfield Clinic Main Campus
Springfield, Illinois, United States
Parkview Research Center at Parkview Regional Medical Center
Fort Wayne, Indiana, United States
Franciscan Health
Indianapolis, Indiana, United States
Baptist Health Lexington
Lexington, Kentucky, United States
Baptist Health Hamburg
Lexington, Kentucky, United States
CHI Saint Joseph Cancer Center - East
Lexington, Kentucky, United States
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana, United States
Ochsner Health Ochsner Cancer Center - Baton Rouge
Baton Rouge, Louisiana, United States
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
New England Cancer Specialists
Westbrook, Maine, United States
University of Maryland
Baltimore, Maryland, United States
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States
Reliant Medical Group
Worcester, Massachusetts, United States
Karmanos Cancer Institute
Detroit, Michigan, United States
Missouri Baptist Medical Center
St Louis, Missouri, United States
Jefferson Health - Cherry Hill
Cherry Hill, New Jersey, United States
Sidney Kimmel Cancer Center - Washington Township
Sewell, New Jersey, United States
Columbia University Irving Medical Center
New York, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Northport VA Medical Center
Northport, New York, United States
Cleveland Clinic
Cleveland, Ohio, United States
Providence Portland Medical Center
Portland, Oregon, United States
Providence St. Vincent Medical Center
Portland, Oregon, United States
Kaiser Permanente Interstate Medical Office Central
Portland, Oregon, United States
Oregon Health and Science University
Portland, Oregon, United States
Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office
Philadelphia, Pennsylvania, United States
Jefferson Hospital Northeast
Philadelphia, Pennsylvania, United States
AHN Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Lexington Medical Center
West Columbia, South Carolina, United States
Tennessee Oncology Chattanooga
Chattanooga, Tennessee, United States
University of Tennessee Medical Center
Knoxville, Tennessee, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
SCRI Oncology Partners
Nashville, Tennessee, United States
Tennessee Oncology
Nashville, Tennessee, United States
The Center for Cancer and Blood Disorders
Fort Worth, Texas, United States
Houston Methodist Hospital
Houston, Texas, United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
USO - Texas Oncology - San Antonio
San Antonio, Texas, United States
USO - Texas Oncology Gulf Coast
Sugar Land, Texas, United States
USO - US Oncology Research Network
The Woodlands, Texas, United States
The University of Vermont Medical Center Inc.
Burlington, Vermont, United States
University of Virginia Health System
Charlottesville, Virginia, United States
VCU Health Adult Outpatient Pavillion
Richmond, Virginia, United States
Swedish Cancer Institute - Edmonds
Edmonds, Washington, United States
Swedish Medical Center
Seattle, Washington, United States
Cancer Care Northwest - Vercler
Spokane Valley, Washington, United States
Northwest Cancer Specialists PC
Vancouver, Washington, United States
University Hospital and UW Health Clinics
Madison, Wisconsin, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Icon Cancer Centre Wesley
Auchenflower, , Australia
Sunshine Coast University Hospital
Birtinya, , Australia
Austin Health
Heidelberg, , Australia
ICON Cancer Centre - Kurralta Park
Kurralta Park, , Australia
Tamworth Hospital
North Tamworth, , Australia
Sir Charles Gairdner Hospital
Perth, , Australia
Goulburn Valley Health
Shepparton, , Australia
Latrobe Regional Health
Traralgon, , Australia
Medizinische Universität Graz
Graz, , Austria
Ordensklinikum Linz GmbH Elisabethinen
Linz, , Austria
Klinik Floridsdorf
Vienna, , Austria
CHIREC - site delta
Auderghem, , Belgium
Antwerp University Hospital
Edegem, , Belgium
UZ Leuven
Leuven, , Belgium
AZ Delta vzw
Roeselare, , Belgium
Fundação Pio XII - Hospital de Câncer de Barretos
Barretos, , Brazil
CTO - Centro de Tratamento Oncológico
Belém, , Brazil
Oncocentro de Minas Gerais
Belo Horizonte, , Brazil
Hospital Tacchini
Bento Gonçalves, , Brazil
Centro de Pesquisa Sao Lucas
Campinas, , Brazil
Centro de Pesquisa Clínica do Instituto do Câncer do Ceará
Fortaleza, , Brazil
Hospital de Cancer de Londrina
Londrina, , Brazil
Liga Norte Riograndense Contra o Câncer
Natal, , Brazil
Hospital São Lucas da PUCRS
Porto Alegre, , Brazil
Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA
Rio de Janeiro, , Brazil
Instituto D'Or Pesquisa e Ensino
Rio de Janeiro, , Brazil
Icesp - Instituto Do Câncer Do Estado de São Paulo
São Paulo, , Brazil
Hospital Sírio Libanês
São Paulo, , Brazil
Hospital Santa Catarina - Paulista
São Paulo, , Brazil
Centro Paulista de Oncologia Clínica
São Paulo, , Brazil
Instituto D'Or de Pesquisa e Ensino (IDOR)
São Paulo, , Brazil
K2 Oncology
Providencia, , Chile
FALP
Santiago, , Chile
Centro de Oncología de Precisión
Santiago, , Chile
Bradfordhill
Santiago, , Chile
Anyang Cancer Hospital
Anyang, , China
Cancer Hospital Chinese Academy of Medical Science
Beijing, , China
China-Japan Friendship Hospital
Beijing, , China
Peking University People's Hospital
Beijing, , China
Beijing Cancer hospital
Beijing, , China
Jilin Cancer Hospital
Changchun, , China
Xiangya Hospital Central South University
Changsha, , China
Xiangya Hospital Central South University
Changsha, , China
Hunan Cancer Hospital
Changsha, , China
Hunan Cancer Hospital
Changsha, , China
The Third People's Hospital of Chengdu (CDTPH)
Chengdu, , China
Sichuan Cancer hospital
Chengdu, , China
West China Hospital, Sichuan University
Chengdu, , China
The Second Affiliated Hospital Chongqing Medical University
Chongqing, , China
The First People's Hospital of Foshan
Foshan, , China
Guangdong Provincial People's Hospital
Guangzhou, , China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, , China
Zhejiang Provincial People's Hospital
Hangzhou, , China
Zhejiang Cancer Hospital
Hangzhou, , China
Zhejiang Cancer Hospital
Hangzhou, , China
The Second Affiliated hospital of Zhejiang University school of medicine
Hangzhou, , China
Harbin Medical University Cancer Hospital
Harbin, , China
Jinan Central Hospital
Jinan, , China
Shandong Cancer Hospital
Jinan, , China
Taizhou Hospital of Zhejiang Province
Linhai, , China
Liuzhou People's Hospital
Liuchow, , China
The First Affiliated Hospital of Henan University of Science &Technology
Luoyang, , China
Guangxi Medical University Affiliated Tumor Hospital
Nanning, , China
The Second People's Hospital of Neijiang
Neijiang, , China
Shanghai Chest Hospital
Shanghai, , China
Fudan University Shanghai Cancer Center
Shanghai, , China
Cancer Hospital of Shantou University Medical College
Shantou, , China
ShenZhen People's Hospital
Shenzhen, , China
Cancer Hospital Chinese Academy of Medical Sciences. Shenzhen Center
Shenzhen, , China
The First Affiliated Hospital of Soochow University
Suzhou, , China
Tianjin Medical University Cancer Institute & Hospital
Tianjin, , China
Tianjin Medical University Cancer Institute & Hospital
Tianjin, , China
Tongji Hospital Tongji Medical,Science & Technology
Wuhan, , China
Hubei Cancer Hospital
Wuhan, , China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, , China
Zhongshan Peoples Hospital
Zhongshan, , China
ZhuZhou Central Hospital
Zhuzhou, , China
Nemocnice AGEL Ostrava - Vitkovice a.s.
Ostrava, , Czechia
Fakultni nemocnice Bulovka
Prague, , Czechia
Hospices Civils de Lyon - Hopital Louis Pradel
Bron, , France
Chu Grenoble Alpes
La Tronche, , France
Centre Leon Berard
Lyon Cedex08, , France
Assistance Publique Hôpitaux de Marseille - Hôpital Nord
Marseille, , France
Centre Antoine-Lacassagne
Nice, , France
Groupe hospitalier Paris saint Joseph
Paris, , France
Hôpital Européen Georges Pompidou
Paris, , France
Institut Curie
Paris, , France
CHU Bordeaux Haut-Leveque
Pessac, , France
Centre Hospitalier Universitaire de Poitiers
Poitiers, , France
Institut Jean Godinot
Reims, , France
Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou
Rennes, , France
Institut de Cancérologie de l'Ouest
Saint-Herblain, , France
CHU de Toulouse - Hopital Larrey
Toulouse, , France
Hôpital Robert Schuman
Vantoux, , France
Gustave Roussy
Villejuif, , France
Vivantes Klinikum im Friedrichshain - Landsberger Allee
Berlin, , Germany
Evangelische Lungenklinik Berlin
Berlin, , Germany
Charité Campus Virchow-Klinikum
Berlin, , Germany
DRK Kliniken Berlin Mitte
Berlin, , Germany
Klinikum Chemnitz
Chemnitz, , Germany
MV-Zentrum für Onkologie und Hämatologie
Cologne, , Germany
Klinikum Köln-Merheim
Cologne, , Germany
Onkologiezentrum Donauwörth
Donauwörth, , Germany
HELIOS Klinikum Erfurt
Erfurt, , Germany
Asklepios Fachkliniken München-Gauting
Gauting, , Germany
Franziskus-Hospital Harderberg
Georgsmarienhütte, , Germany
LungenClinic Grosshansdorf
Großhansdorf, , Germany
Krankenhaus Martha-Maria Halle-Dölau
Halle, , Germany
Asklepios Klinik Harburg
Hamburg, , Germany
Thoraxklinik-Heidelberg gGmbH
Heidelberg, , Germany
Evangelisches Krankenhaus Herne - Eickel
Herne, , Germany
St. Elisabeth-Krankenhaus Leipzig
Leipzig, , Germany
Klinikum Nürnberg Nord
Nuremberg, , Germany
Robert Bosch Krankenhaus GmbH
Stuttgart, , Germany
Universitaetsklinikum Tuebingen
Tübingen, , Germany
Agios Savvas Regional Cancer Hospital
Athens, , Greece
Errikos Dunant Hospital Center
Athens, , Greece
Thoracic General Hospital of Athens "I Sotiria"
Athens, , Greece
University General Hospital of Heraklion
Heraklion, , Greece
University General Hospital of Larissa
Larissa, , Greece
University Hospital of Patras
Pátrai, , Greece
Agios Loukas Clinic
Thessaloniki, , Greece
European Interbalkan Medical Center
Thessaloniki, , Greece
Országos Onkológiai Intézet
Budapest, , Hungary
Budapesti Uzsoki Utcai Kórház
Budapest, , Hungary
Farkasgyepui Tudogyogyintezet
Farkasgyepű, , Hungary
Hemato Oncology Clinic
Ahmedabad, , India
Galaxy Superspeciality Hospital
Aurangabad, , India
Rajiv Gandhi Government General Hospital
Chennai, , India
Sir H. N. Reliance Foundation Hospital and Research Centre
Mumbai, , India
Thangam Cancer Center - Namakkal
Namakkal, , India
Savera Cancer & Multi Speciality Hospital
Patna, , India
Deenanath Mangeshkar Hospital & Research Centre
Pune, , India
Medipoint Hospitals Pvt. Ltd.
Pune, , India
Malabar Cancer Centre - Thalassery
Thalassery, , India
Regional Cancer Centre - Thiruvananthapuram
Thiruvananthapuram, , India
Pacific Medical College & Hospital
Udaipur, , India
Tata Memorial Centre - Homi Bhabha Cancer Hospital
Varanasi, , India
Rambam Health Care Campus
Haifa, , Israel
Shaare Zedek Medical Center
Jerusalem, , Israel
Meir Medical Center
Kfar Saba, , Israel
Sheba Medical Center
Ramat Gan, , Israel
Instituto Tumori Giovanni Paolo II
Bari, , Italy
Policlinico "G. Rodolico"
Catania, , Italy
Ospedale San Martino
Genova, , Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Meldola, , Italy
ASST Grande Ospedale Metropolitano Niguarda
Milan, , Italy
Ospedale San Gerardo-ASST Monza
Monza, , Italy
Azienda Ospedaliera Dei Colli
Naples, , Italy
Azienda Sanitaria Ospedaliera S Luigi Gonzaga
Orbassano, , Italy
Istituto Nazionale Tumori Regina Elena
Rome, , Italy
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento
Verona, , Italy
Juntendo University Hospital
Bunkyō City, , Japan
Tokyo Metropolitan Komagome Hospital
Bunkyō City, , Japan
Kyushu University Hospital
Fukuoka, , Japan
Saitama Medical University International Medical Center
Hidaka, , Japan
Himeji Medical Center
Himeji, , Japan
Kansai Medical University Hospital
Hirakata, , Japan
Kanazawa University Hospital
Kanazawa, , Japan
National Cancer Center Hospital East
Kashiwa, , Japan
The Cancer Institute Hospital of JFCR
Kōtō City, , Japan
University Hospital,Kyoto Prefectural University of Medicine
Kyoto, , Japan
Shizuoka Cancer Center
Nagaizumi-cho,Sunto-gun, , Japan
Aichi Cancer Center Hospital
Nagoya, , Japan
Miyagi Cancer Center
Natori, , Japan
Niigata Cancer Center Hospital
Niigata, , Japan
Kindai University Hospital- Osakasayama Campus
Sakai, , Japan
NHO Kinki Chuo Chest Medical Center
Sakai, , Japan
Hokkaido University Hospital
Sapporo, , Japan
Wakayama Medical University Hospital
Wakayama, , Japan
Kanagawa Cardiovascular and Respiratory Center
Yokohama, , Japan
Kanagawa cancer center
Yokohama, , Japan
Tottori University Hospital
Yonago, , Japan
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL)
Amsterdam, , Netherlands
Amsterdam UMC, locatie VUmc
Amsterdam, , Netherlands
Amphia Ziekenhuis, locatie Breda Molengracht
Breda, , Netherlands
Ziekenhuis St. Jansdal
Harderwijk, , Netherlands
ETZ Elisabeth
Tilburg, , Netherlands
St. Antonius Ziekenhuis, locatie Utrecht
Utrecht, , Netherlands
Isala, locatie Zwolle
Zwolle, , Netherlands
Sorlandet Sykehus Arendal
Arendal, , Norway
Haukeland Universitetssjukehus
Bergen, , Norway
Drammen Sykehus, Vestre Viken HF
Drammen, , Norway
Sykehuset Innlandet HF Gjøvik
Gjøvik, , Norway
Oslo universitetssykehus, Radiumhospitalet
Oslo, , Norway
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej
Kielce, , Poland
Wielkopolskie Centrum Pulmonologii i Torakochirurgii
Poznan, , Poland
One Day Med
Szczecin, , Poland
Centro Hospitalar E Universitário De Coimbra
Coimbra, , Portugal
Hospital da Luz Lisboa
Lisbon, , Portugal
Hospital CUF Porto
Porto, , Portugal
Instituto Português de Oncologia do Porto Francisco Gentil, EPE
Porto, , Portugal
Lotus-Med
Bucharest, , Romania
SC Memorial Healthcare International SRL
Bucharest, , Romania
Institutul Oncologic
Cluj-Napoca, , Romania
Ovidius Clinical Hospital OCH
Ovidiu, , Romania
Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica
Banská Bystrica, , Slovakia
Univerzitná nemocnica Bratislava - Nemocnica Ružinov
Bratislava, , Slovakia
Vychodoslovensky Onkologicky ustav a.s.
Košice, , Slovakia
The Catholic University of Korea, Incheon St. Mary's Hospital
Bupyeong-gu, , South Korea
Pusan National University Hospital
Busan, , South Korea
Chungbuk National University Hospital
Cheongju-si, , South Korea
Keimyung University Dongsan Hospital
Daegu, , South Korea
Kyungpook National University Chilgok Hospital
Deagu, , South Korea
Gangnam Severance Hospital, Yonsei University Health System
Gangnam-gu, , South Korea
National Cancer Center
Goyang-si, , South Korea
Chonnam National University Hwasun Hospital
Hwasun-gun, , South Korea
Yeungnam Univeristy Medical Center
Nam-gu, , South Korea
Seoul National University Bundang Hospital
Seongnam, , South Korea
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Seoul, , South Korea
Severance Hospital, Yonsei University Health System
Seoul, , South Korea
Konkuk University Medical Center
Seoul, , South Korea
Asan Medical Center
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
The Catholic Univ. of Korea Seoul St. Mary's Hospital
Seoul, , South Korea
The Catholic University of Korea, Yeouido St. Mary's Hospital
Seoul, , South Korea
Korea University Guro Hospital
Seoul, , South Korea
The Catholic University Of Korea St. Vincent's Hospital
Suwon, , South Korea
Pusan National University Yangsan Hospital
Yangsan, , South Korea
Hospital Infanta Cristina
Badajoz, , Spain
Parc de Salut Mar - Hospital del Mar
Barcelona, , Spain
Hospital Universitari Vall d'Hebron
Barcelona, , Spain
Hospital Clínic de Barcelona
Barcelona, , Spain
Instituto Catalan de Oncologia - Hospital Duran i Reynals
Hospitalet, , Spain
Hospital Jerez de la Frontera
Jerez de la Frontera, , Spain
Hospital Insular de Gran Canaria
Las Palmas de Gran Canaria, , Spain
Hospital General Universitario Gregorio Marañon
Madrid, , Spain
Hospital Universitario Ramón y Cajal
Madrid, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
H.R.U Málaga - Hospital General
Málaga, , Spain
Hospital Universitari Son Espases
Palma, , Spain
Complejo Hospitalario de Navarra
Pamplona, , Spain
Hospital Universitario Quironsalud Madrid
Pozuelo de Alarcón, , Spain
CHUS - Hospital Clinico Universitario
Santiago de Compostela, , Spain
Hospital Universitario Virgen Del Rocio
Seville, , Spain
Hospital Clinico de Valencia
Valencia, , Spain
Hospital Clínico Universitario Lozano Blesa
Zaragoza, , Spain
Sahlgrenska Universitetssjukhuset
Gothenburg, , Sweden
Kantonsspital Baden
Baden, , Switzerland
HFR Fribourg - Hôpital Cantonal
Fribourg, , Switzerland
Kouros Moccia Oncologia
Locarno, , Switzerland
Changhua Christian Hospital
Changhua County, , Taiwan
Buddhist Dalin Tzu Chi General Hospital
Chiayi City, , Taiwan
National Taiwan University Hospital Yun-Lin Branch Dou-Liou Region
Douliu, , Taiwan
Hualien Tzu Chi Medical Center
Hualien City, , Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, , Taiwan
E-Da hospital
Kaohsiung City, , Taiwan
Chang Gung Memorial Hospital at Kaohsiung
Kaohsiung Niao Sung Dist, , Taiwan
Far Eastern Memorial Hospital
New Taipei City, , Taiwan
New Taipei Municipal TuCheng Hospital
New Taipei City, , Taiwan
Chung Shan Medical University Hospital
Taichung, , Taiwan
Taichung Veterans General Hospital
Taichung, , Taiwan
National Cheng Kung University Hospital
Tainan, , Taiwan
Chi Mei Medical Center
Tainan, , Taiwan
Chi Mei Hospital - Liouying Branch
Tainan, , Taiwan
National Taiwan University Hospital
Taipei, , Taiwan
National Taiwan University Cancer Center (NTUCC)
Taipei, , Taiwan
Taipei Veterans General Hospital
Taipei, , Taiwan
Chang Gung Medical Foundation-Linkou Branch
Taoyuan District, , Taiwan
Baskent University Dr. Turgut Noyan Research and Training Center
Adana, , Turkey (Türkiye)
Adana City Hospital
Adana, , Turkey (Türkiye)
Sakarya University School of Medicine
Adapazarı, , Turkey (Türkiye)
University of Health Sciences,Gulhane School of Medicine
Ankara, , Turkey (Türkiye)
Antalya Egitim ve Arastırma Hastanesi
Antalya, , Turkey (Türkiye)
Trakya University
Edirne, , Turkey (Türkiye)
Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
Gaziantep, , Turkey (Türkiye)
İ.A.Ü VM Medical Park Florya Hastanesi
Istanbul, , Turkey (Türkiye)
Izmir Atatürk Training and Research Hospital
Izmir, , Turkey (Türkiye)
Marmara Universitesi Pendik Egitim Arastirma Hastanesi
Pendik, , Turkey (Türkiye)
Samsun Medical Park Hastanesi
Samsun, , Turkey (Türkiye)
Heartlands Hospital
Birmingham, , United Kingdom
University Hospitals Sussex NHS Foundation Trust
East Sussex, , United Kingdom
Huddersfield Royal Infirmary
Huddersfield, , United Kingdom
Royal Marsden Hospital (Sutton)
London, , United Kingdom
Royal Marsden Hospital (Chelsea)
London, , United Kingdom
The Christie NHS Foundation Trust
Manchester, , United Kingdom
Torbay Hospital
Torquay, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
Role: CONTACT
Physicians interested in becoming principal investigators please contact
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer (SUNRAY-02)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-512302-25-00
Identifier Type: CTIS
Identifier Source: secondary_id
J3M-MC-JZQH
Identifier Type: OTHER
Identifier Source: secondary_id
18763
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.